TNXP (STOCKS)
Tonix Pharmaceuticals Holding Corp.
$12.990000
+0.510000 (+4.09%)
Prev close: $12.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Seth Lederman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $173.87M
- Employees
- 81
- P/E (TTM)
- -0.91
- P/B (TTM)
- 0.65
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $13.11M |
| Benefits Costs and Expenses | $138.81M |
| Cost Of Revenue | $6.64M |
| Costs And Expenses | $138.81M |
| Gross Profit | $6.47M |
| Operating Expenses | $132.17M |
| Selling, General, and Administrative Expenses | $87.68M |
| Depreciation and Amortization | $1.90M |
| Research and Development | $44.49M |
| Operating Income/Loss | -$125.70M |
| Income/Loss From Continuing Operations After Tax | -$124.02M |
| Income/Loss From Continuing Operations Before Tax | -$125.70M |
| Net Income/Loss | -$124.02M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$124.02M |
| Net Income/Loss Available To Common Stockholders, Basic | -$124.02M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$14.57 |
| Diluted Earnings Per Share | -$14.57 |
| Basic Average Shares | 8,511,318 |
| Diluted Average Shares | 8,511,318 |
| Assets | $277.17M |
| Current Assets | $228.88M |
| Noncurrent Assets | $48.30M |
| Fixed Assets | $44.46M |
| Intangible Assets | $120.00K |
| Other Non-current Assets | $3.72M |
| Liabilities | $32.02M |
| Current Liabilities | $30.84M |
| Accounts Payable | $8.11M |
| Other Current Liabilities | $22.72M |
| Noncurrent Liabilities | $1.18M |
| Equity | $245.15M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $245.15M |
| Liabilities And Equity | $277.17M |
| Net Cash Flow From Operating Activities | -$99.84M |
| Net Cash Flow From Operating Activities, Continuing | -$99.84M |
| Net Cash Flow From Investing Activities | -$4.53M |
| Net Cash Flow From Investing Activities, Continuing | -$4.53M |
| Net Cash Flow From Financing Activities | $214.53M |
| Net Cash Flow From Financing Activities, Continuing | $214.53M |
| Exchange Gains/Losses | -$31.00K |
| Net Cash Flow | $110.13M |
| Net Cash Flow, Continuing | $110.16M |
| Comprehensive Income/Loss | -$124.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$124.06M |
| Other Comprehensive Income/Loss | -$124.06M |